IG3018

· Intelligem Therapeutics Australia Pty Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IG3018, covering 2026-02-03 to 2026-02-03. Get the full timeline:

Most recent: Clinical Trial Update: A Dose Escalation Study of IG3018 in Subjects With Hyperuricemia With or Without Chronic Kidney Disease [Phase 1, Phase 2]

See pricing